Header

Main Content

Article

Medical Licensing Board of Indiana

COVID-19 Actions

Waiver of Out-of-State Licensure Verification by Board: The Indiana Medical Licensing board is temporarily waiving the application of 844 IAC 4-4.5-7(a)(8) insofar as it requires applicants for licensure who are licensed in another state to have verification sent by the state that issued that license directly to the board. This waiver is temporary during the public health emergency and will be effective immediately once the emergecny is lifted. A copy of the order may be found HERE

Guidance for Prescribing and Dispensing of COVID-19 Related Drugs: The Indiana Board of Pharmacy and Medical Licensing Board have issued a joint statement providing guidance to healthcare professionals relating to prescribing and dispensing of hydroxychloroquine, chloroquine, and azithromycin. The guidance discourages these drugs from being prescribed for prophylactic use for COVID-19 and encourages professional caution in fulfilling any prescription of these drugs. Additionally, the boards are suggesting that any prescription for these drugs be limited to a 14-day supply wherever medically appropriately. A copy of the guidance may be found HERE

Controlled Substance Prescribing via Telemedicine- IC 25-1-9.5-8: Pursuant to Executive Order 20-13, a prescriber may prescribe a Schedule II-V controlled substance via telemedicine as long as the following conditions are met:
1. The prescription is issued for a legitimate medical purpose by a prescriber acting in their usual professional practice; 
2. The initial telecommunication is conducted using an audio-visual, real-time, two-way interactive communication system; and
3. All other applicable state and federal laws are followed.

Once a prescriber has conducted an in-person medical evaluation or has conducted an evaluation using an audio-visual, real-time, two-way interactive communication system for the initial prescription; further health consultation may be done via audio-only or audio-visual telecommunication, as long as all other applicable state and federal laws are followed.

Critical Fingerprinting: The following license types have been deemed critial by the Indiana Department of Administration and will be given priority for the purposes of getting fingerprinting completed. 
License Types: Physician, Osteopathic Physician

PLA Remote Work: In response to COVID-19 and the impact it is having on the State of Indiana, the Professional Licensing Agency will have the majority of our staff working remotely in the coming weeks. While routine operations of the agency will continue, please note that there may be disruptions or delays in the processing of your requests. Please prioritize the usage of email to communicate with our staff whenever possible and scan any documents that need to be processed. We appreciate your patience and flexibility as we work best to protect our staff and serve Hoosiers in these ever-changing times.

 

Legislative Notices
Licensing Information
Resources
Board Information
Consumer/Patient Information
Staff Information

Legislative Notices

Gabapentin reporting to INSPECT:

Effective July 1st, 2019, pursuant to House Enrolled Acts 1246 and 1542, the Indiana scheduled prescription electronic collection and tracking (INSPECT) program will begin monitoring and tracking the prescribing and dispensation of Gabapentin. Please note, this change solely provides for the monitoring and inclusion of Gabapentin in the INSPECT database and does not schedule or affect the prescribing of Gabapentin.

For more information and a copy of House Enrolled Act 1246 or House Enrolled Act 1542, please visit the Indiana General Assembly website at iga.in.gov.

 

Continuing Education requirements for Controlled Substance Registrants and Re-registrants:

Effective July 1st, 2019, pursuant to Senate Enrolled Act 225-2018, a practitioner who is licensed by a board and applies for registration or re-registration to distribute or dispense a controlled substance must have completed two (2) hours of continuing education during the previous two (2) years addressing the topic of opioid prescribing and opioid abuse.

For more information and a copy of Senate Enrolled Act 225-2018, please visit the Indiana General Assembly website at iga.in.gov. Additional information is available below in the "Licensing Section."

 

Mandatory INSPECT registration & query laws

  • Registration for the INSPECT database: IC 35-48-7-11.3

    • Beginning January 1, 2019, a practitioner who is permitted to distribute, dispense, prescribe,conduct research with respect to, or administer ephedrine, pseudoephedrine, or a controlled substance in the course of the practitioner's professional practice or research in the United States must be certified under section 11.1(d)(4) of this chapter to receive information from the INSPECT program.

  • Mandatory Query of the INSPECT database in certain instances: IC 35-48-7-11.1

    • Beginning July 1, 2018, A practitioner who has had the information from the data base integrated into the patient's electronic health records.

    • Beginning January 1, 2019, a practitioner who provides services to the patient in the emergency department of a hospital licensed under IC 16-21 or  a pain management clinic.

    • Beginning January 1, 2020, a practitioner who provides services to the patient in a hospital licensed under IC 16-21.

    • Beginning January 1, 2021, all practitioners.

Senate Enrolled Act 221 is effective July 1st, 2018 with subsequent rolling effective dates for mandatory query when prescribing in certain circumstances. 

The full text of the bill can be found at the following link: iga.in.gov

For more information or to sign up your facility for the Statewide Integration Initiative, visit the INSPECT website at the following address: https://www.in.gov/pla/inspect

 

Licensing Information

Information regarding Fees

Due to statutory requirements regarding processing times for application fees, the Indiana Professional Licensing Agency will no longer accept more than ten (10) fees per individual check for the application or renewal of a medical license with the Medical Licensing Board of Indiana.

If a check is received with more than ten (10) fees per check, it may result in the return of your check along with the applications or renewals to your program for correction.  Further delays in processing time, as a result of more than ten (10) fees per check, may also lead to potential late fees. We apologize for any inconvenience this may cause and appreciate your partnership as we continue to work together to issue licenses as quickly and efficiently as possible. 

Apply for a license as a Physician/Osteopathic Physician:

Apply for a temporary medical permit:

Apply for a controlled substances registration:

Apply for a limited scope permit:

Additional Information for Applicants:

Additional Information for Licensees:

For information regarding acupuncture licenses, please click here.

For information regarding diabetes educator licenses, please click here.

For information regarding genetic counselors, please click here.

For information regarding anesthesiologist assistants, please click here.

For information regarding dietitians, please click here

Resources

Board Approved Psychiatrists & Addictionologists  Updated as of 3.2.2016
Directory of Physician Assessment and Remedial Education Programs
Fee Schedule
High Breast Density Information 
LCME Standards
Office Based Procedures
Physician Assistance Program
Practice Related Frequently Asked Questions
Statutes and Rules
Verify License to another State
Wall Certificates & Pocket Cards



Medical Licensing Board Information

About the Medical Licensing Board
Board Meeting Dates
Board Minutes & Agendas
Electronic Meeting Policy

Consumer/Patient Information


Look up a Doctor
Look up Disciplinary Information
Look up Malpractice Claims - directs to Indiana Department of Insurance
DocInfo.org - maintained by Federation of State Medical Boards
Medicare/Medicaid/Federal health care program Exclusion List look-up - directs to U.S. Health & Human Services, Office of Inspector General
File a Complaint - directs to Indiana Attorney General
File a Death Certificate Complaint

The Board does not maintain records of hospital disciplinary actions, federal disciplinary actions, or convictions. 

Staff Information

Laura Turner, J.D., Board Director
, Assistant Board Director
Donna Moran, Litigation Specialist
Meredith Shirley, Customer Service Representative
Zharia Collins, Customer Service Representative
Elizabeth Sangar, Customer Service Representative
Tiffany Finnell, Customer Service Representative

Staff Phone Number: (317) 234-2060
Staff Fax Number: (317) 233-4236
Staff Email:
pla3@pla.in.gov

Indiana Professional Licensing Agency
Attn: Medical Licensing Board of Indiana
402 W. Washington Street, W072
Indianapolis, Indiana 46204